The FDA has some catching up to do on establishing clear regulations around a new class of medical devices known as “Software-as-a-Medical Device (SaMD).”

Currently, technological and scientific advances are outpacing the regulators and without specific rule-sets for these innovations, many safety and security requirements and liability questions remain unknown.

Peter A. Levy explores these healthcare technology issues in a recent article in ROI-NJ.